论文专著:
发表论文:
1. Zhu Y#, Li H#, Hu L, Wang J, Zhou Y, Pang Z, Liu L, Shao F. Structure of a Shigella Effector Reveals a Novel Class of Ubiquitin Ligases. Nature Structural & Molecular Biology, 2008, 15: 1302-1308. (IF:12.2)
2. Zhu Y#, Li H#, Long C#, Hu L, Xu H, Liu L, Chen S, Wang D, Shao F. Structure insights into the enzymatic mechanism of the pathogenic MAPK phosphothreonine lyase. Molecular Cell, 2007, 28: 899-914 (IF:14.6)
3. Zhang J , Shao F , Li Y , Cui H , Chen L, Li H, Zou Y, Long C, Lan L, Chai J, Chen S, Tang X, Zhou J. A Pseudomonas syringae Effector Inactivates MAPKs to Suppress PAMP-Induced Immunity in Plants. Cell Host and Microbe, 2007; 1: 175-185. (IF:13.0)
4. Li H#, Xu H#, Zhou Y#, Zhang J, Long C, Li S, Chen S, Zhou J, Shao, F. The phosphothreonine lyase activity of a bacterial type III effector family. Science. 2007; 315: 1000-1003. (IF:29.7)
5. Du H, Li H, Zhang F, Lin X, Shi J, Shi Y, Ji L, Hu J, Lin D, Hu H. Acceleration of alpha-synuclein aggregation by homologous peptides. FEBS Lett. 2006;580: 3657-64.
6. Tang L, Li H, Du H, Zhang F, Hu X, Hu H. Study of the disassembly-assembly process of alpha-synuclein fibrils by in situ atomic force microscopy. Micron. 2006, 37: 675-9.
7. Li H, Lin D, Luo X, Zhang F, Ji L, Du H, Song G, Hu J, Zhou J, Hu H.Inhibition of alpha-synuclein fibrillization by dopamine analogs via reaction with the amino groups of alpha-synuclein. Implication for dopaminergic neurodegeneration. FEBS J. 2005; 272: 3661-72.
8. Du H, Tang L, Luo X, Li H, Hu J, Zhou J, Hu H. A peptide motif consisting of glycine, alanine, and valine is required for the fibrillization and cytotoxicity of human alpha-synuclein. Biochemistry. 2003; 42: 8870-8.
9. Li H, Du H, Tang L, Hu J, Hu H. Structural transformation and aggregation of human alpha-synuclein in trifluoroethanol: non-amyloid component sequence is essential and beta-sheet formation is prerequisite to aggregation. Biopolymers. 2002; 64: 221-6.